R.PR
REGISTERED-PRINCIPAL REGISTER
10/26/2021
Back to search
Official data from USPTO
RADX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
RADX
ST13
US500000090226491Class
35, 36, 41, 42
Filing
90226491
Registration
6534475
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
10/26/2021
Trademark type
Word
Nice classes
35, 36, 41, 42
Filing date
09/30/2020
Registration date
10/26/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/26/2021
Last transaction
10/26/2021
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
04/29/2020
First use in commerce
04/29/2020
Drawing code
4
Owner type
99
Owner location
Bethesda, MD, US
Examiner
BAKER, JORDAN A
Law office
O30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
U.S. Department of Health and Human Services
Representatives
Angela Y. Dai OFFICE OF THE GENERAL COUNSEL
Technical classification
Nice Classes
Class 35Class 36Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Promoting researchdevelopmentvalidationcommercializationimplementation of testing technologies for pathogens; promoting researchdevelopmentvalidationcommercializationimplementation of testing technologies for viruses; promoting researchdevelopmentvalidationcommercializationimplementation of testing technologies for viruses that cause COVID-19 and influenza flu; promoting improvement of clinical laboratory testing technologies for COVID-19 and influenza flu; promoting researchdevelopmentvalidationcommercializationimplementation of testing technologies for pathogens through support of scientific organizationsresearch institutionsmedical institutionsacademic institutionsnon-profit organizationsbusiness entities; promoting researchdevelopmentvalidationcommercializationimplementation of testing technologies for viruses that cause COVID-19 and influenza flu through support of scientific organizationsresearch institutionsmedical institutionsacademic institutionsnon-profit organizationsbusiness entities; promoting collaboration within the scientificresearchmedicalacademicbusiness communities to advance researchdevelopmentcommercializationimplementation of testing technologies for pathogens; promoting collaboration within the scientificresearchmedicalacademicbusiness communities to advance researchdevelopmentcommercializationimplementation of testing technologies for viruses that cause COVID-19 and influenza flu; promoting collaboration within the technology innovatorclinical testingregulatory affairsentrepreneurbusiness leadercommunity leader networks to advance researchdevelopmentcommercializationimplementation of testing technologies for pathogens; promoting collaboration within the technology innovatorclinical testingregulatory affairsentrepreneurbusiness leadercommunity leader networks to advance researchdevelopmentcommercializationimplementation of testing technologies for viruses that cause COVID-19 and influenza flu; promoting community-engaged projects to assess and expand availability of testing technologies for pathogens in underserved and/or vulnerable populations; promoting community-engaged projects to assess and expand availability of testing technologies for viruses that cause COVID-19 and influenza flu in underserved and/or vulnerable populations; promoting collaboration between the scientific research community and underserved and/or vulnerable populations to achieve increased accessibility and availability of testing technologies for pathogens in underserved and/or vulnerable populations; promoting collaboration between the scientific research community and underserved and/or vulnerable populations to achieve increased accessibility and availability of testing technologies for viruses that cause COVID-19 and influenza flu in underserved and/or vulnerable populations; promoting rapid scale-up of testing technologies for pathogens; promoting rapid scale-up of testing technologies for viruses that cause COVID-19 and influenza flu; promoting increased availability of testing technologies for pathogens; promoting increased availability of testing technologies for viruses that cause COVID-19 and influenza flu; administration and management of research grants; administration of programs for promoting researchdevelopmentvalidationcommercializationimplementation of testing technologies for pathogens; administration of programs for promoting researchdevelopmentvalidationcommercializationimplementation of testing technologies for viruses that cause COVID-19 and influenza flu
Class 36
Providing grants and financial support for biomedical research and development; providing grants and financial support for biomedical engineering; providing grants and financial support for researchdevelopmentvalidationcommercializationimplementation of testing technologies for pathogens; providing grants and financial support for researchdevelopmentvalidationcommercializationimplementation of testing technologies for viruses; providing grants and financial support for researchdevelopmentvalidationcommercializationimplementation of testing technologies for viruses that cause COVID-19 and influenza flu; providing grants and financial support for community-engaged projectsestablishment of clinical research sites and testing centers in underserved and/or vulnerable communities; providing information regarding funding opportunities relating to biomedical and scientific research and developments via a website
Class 41
Providing a website featuring blogsnon-downloadable videosnon-downloadable videocastseducational presentations in the nature of seminarsforumsnon-downloadable webinars relating to medicalbiomedical and scientific research information and distribution of educational materials in connection therewith
Class 42
Providing a website featuring medicalbiomedical and scientific research information; providing a website featuring news in the field of biomedical and scientific research and developments; providing a website featuring biomedical and scientific research information and developmentsdashboards displaying biomedical and scientific research datainformation and developments
Publications
History of USPTO decisions and trademark events.
20 publications found
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/10/2021
PUBO
PUBLISHED FOR OPPOSITION
08/10/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/21/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/08/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/21/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/21/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/21/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/25/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/25/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/25/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/21/2020
GNRT
NON-FINAL ACTION E-MAILED
12/21/2020
CNRT
NON-FINAL ACTION WRITTEN
12/21/2020
DOCK
ASSIGNED TO EXAMINER
12/21/2020
PCGR
PETITION TO DIRECTOR GRANTED
12/18/2020
APET
ASSIGNED TO PETITION STAFF
12/17/2020
TPDR
TEAS PETITION TO DIRECTOR RECEIVED
11/16/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/14/2020
NWAP
NEW APPLICATION ENTERED
10/03/2020
Continuous trademark protection
Get notified about every new filing that threatens RADX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.